New therapies, such as chimeric antigen receptor T (CAR-T) cell therapy, require further research.[10] In this systematic review, we summarized the characteristics and prognostic significance of the SET-CAN fusion gene in hematological malignancies. This evidence concerns the gene NUP214 and hematologic disorder.